<http://www.reactome.org/biopax/48892Evidence2289> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.biopax.org/release/biopax-level3.owl#Evidence> .
<http://www.reactome.org/biopax/48892Evidence2289> <http://www.biopax.org/release/biopax-level3.owl#comment> "Upon phosphorylation of the R-SMAD (SMAD2/3), the conformation of the C-terminal (MH2) domain of the R-SMAD changes, lowering its affinity for the type I receptor and SARA. As a result, the phosphorylated R-SMAD dissociates from the activated receptor complex (TGFBR)."^^<http://www.w3.org/2001/XMLSchema#string> .
<http://www.reactome.org/biopax/48892Evidence2289> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/17356069> .
<http://www.reactome.org/biopax/48892Evidence2289> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/9136927> .
<http://www.reactome.org/biopax/48892Evidence2289> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/8893010> .
<http://www.reactome.org/biopax/48892Evidence2289> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/15350224> .
<http://www.reactome.org/biopax/48892Evidence2289> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/9311995> .
<http://www.reactome.org/biopax/48892Evidence2289> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/8980228> .
<http://www.reactome.org/biopax/48892Evidence2289> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/9346966> .
<http://www.reactome.org/biopax/48892Evidence2289> <http://www.biopax.org/release/biopax-level3.owl#evidenceCode> <http://www.reactome.org/biopax/48892EvidenceCodeVocabulary1> .